67 related articles for article (PubMed ID: 11505619)
1. Clinical outcomes and failure patterns after postoperative radiotherapy for oral cavity squamous cell carcinoma.
Tatsuno S; Doi H; Inada M; Uehara T; Wada Y; Ishikawa K; Tanaka K; Kitano M; Nishimura Y
Strahlenther Onkol; 2024 May; 200(5):389-399. PubMed ID: 37999789
[TBL] [Abstract][Full Text] [Related]
2. Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1-2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study.
Lin CY; Chen WC; Wen YW; Fan KH; Lin JC; Ng SH; Tsai YT; Lee SR; Kang CJ; Lee LY; Chien CY; Hua CH; Wang CP; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
Cancer Med; 2024 May; 13(10):e7127. PubMed ID: 38770540
[TBL] [Abstract][Full Text] [Related]
3. Interstitial brachytherapy for lip carcinomas: Comparison between Ir-192 low-dose-rate and high-dose-rate treatment.
Cuenin M; Salleron J; Peiffert D; Meknaci É; Gallet P; Abushama Y; Py JF; Renard S
Cancer Radiother; 2024 Apr; 28(2):145-151. PubMed ID: 38072744
[TBL] [Abstract][Full Text] [Related]
4. Image-guided Interstitial Brachytherapy in the Treatment of Primary and Recurrent Vulvovaginal Gynaecological Malignancies.
Sarwar A; Syed L; Patel K; Reid I; Abonyi E; Banas N; Lowe G; Bryant L; Hoskin P
Clin Oncol (R Coll Radiol); 2024 Jan; 36(1):6-11. PubMed ID: 37923687
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patients.
Renard S; Demogeot N; Bruand M; Sahki N; Marchesi V; Gehin W; Meknaci E; Peiffert D
J Contemp Brachytherapy; 2024 Feb; 16(1):21-27. PubMed ID: 38584888
[TBL] [Abstract][Full Text] [Related]
6. Can interventional radiotherapy (brachytherapy) be an alternative to surgery in early-stage oral cavity cancer? A systematic review.
Draghini L; Lancellotta V; Fionda B; De Angeli M; Cornacchione P; Massaccesi M; Trippa F; Kovács G; Morganti AG; Bussu F; Iezzi R; Tagliaferri L
Strahlenther Onkol; 2024 May; 200(5):367-376. PubMed ID: 38108835
[TBL] [Abstract][Full Text] [Related]
7. Putting the Brakes on Xerostomia in Oropharyngeal Cancer: Can Brachytherapy Be the Key?
McVorran S; Naghavi A; Schaner P
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):302-303. PubMed ID: 38631740
[No Abstract] [Full Text] [Related]
8. Embryonal tumor with multilayered rosettes located in the brainstem: Promising results after multimodal treatment including interstitial brachytherapy.
Jünger ST; Rueß D; Kabbasch C; Gielen GH; Pietsch T; Johann P; Landgraf P; Kocher M; Goldbrunner R; Simon T; Ruge MI
Neurooncol Pract; 2024 Apr; 11(2):216-218. PubMed ID: 38496916
[No Abstract] [Full Text] [Related]
9. Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost.
Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Friesland S
Radiat Oncol; 2023 Apr; 18(1):65. PubMed ID: 37029424
[TBL] [Abstract][Full Text] [Related]
10. Is There Still a Place for Brachytherapy in the Modern Treatment of Early-Stage Oral Cancer?
Tuček L; Vošmik M; Petera J
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008386
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection.
Chyrek AJ; Bielęda GMB; Burchardt WM; Chicheł A; Wojcieszek PA
J Contemp Brachytherapy; 2019 Apr; 11(2):116-121. PubMed ID: 31139219
[TBL] [Abstract][Full Text] [Related]
12. Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.
Kovács G
J Contemp Brachytherapy; 2015 Jan; 6(4):404-16. PubMed ID: 25834586
[TBL] [Abstract][Full Text] [Related]
13. 125I brachytherapy alone for recurrent or locally advanced adenoid cystic carcinoma of the oral and maxillofacial region.
Huang MW; Zheng L; Liu SM; Shi Y; Zhang J; Yu GY; Zhang JG
Strahlenther Onkol; 2013 Jun; 189(6):502-7. PubMed ID: 23625361
[TBL] [Abstract][Full Text] [Related]
14. Oral cancer: Current role of radiotherapy and chemotherapy.
Huang SH; O'Sullivan B
Med Oral Patol Oral Cir Bucal; 2013 Mar; 18(2):e233-40. PubMed ID: 23385513
[TBL] [Abstract][Full Text] [Related]
15. Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.
Peterson DE; Doerr W; Hovan A; Pinto A; Saunders D; Elting LS; Spijkervet FK; Brennan MT
Support Care Cancer; 2010 Aug; 18(8):1089-98. PubMed ID: 20526784
[TBL] [Abstract][Full Text] [Related]
16. Free flap transfer in cranio-maxillofacial surgery: a review of the current data.
Thorwarth M; Eulzer C; Bader R; Wolf C; Schmidt M; Schultze-Mosgau S
Oral Maxillofac Surg; 2008 Sep; 12(3):113-24. PubMed ID: 18575905
[TBL] [Abstract][Full Text] [Related]
17. [Brachytherapy in combination with function-preserving surgery. An interdisciplinary challenge].
Meyer JE; Brocks C; Gehrking E; Kovács G; Neppert B; Gliemroth J; Wollenberg B
HNO; 2008 Apr; 56(4):471-8. PubMed ID: 18347764
[TBL] [Abstract][Full Text] [Related]
18. Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy.
Pellizzon AC; Salvajoli JV; Kowalski LP; Carvalho AL
Radiat Oncol; 2006 Aug; 1():27. PubMed ID: 16895605
[TBL] [Abstract][Full Text] [Related]
19. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.
Grabenbauer GG; Rödel C; Brunner T; Schulze-Mosgau S; Strnad V; Müller RG; Iro H; Sauer R
Strahlenther Onkol; 2001 Jul; 177(7):338-44. PubMed ID: 11505619
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
